Yuhan Corporation
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 000105.KS | 000220.KS | 128940.KS | 016580.KS | 023910.KQ | 000640.KS | |
|---|---|---|---|---|---|---|
| Market cap | 5.18T | 57.48B | 4.59T | 188.54B | 148.76B | 604.34B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | — | — | — | — | — |
| Price/book | — | — | — | — | — | — |
| Dividend yield | 0.87% | 3.12% | 0.54% | 2.94% | 3.94% | 1.87% |
| 1-year change | −32.56% | −11.74% | +9.29% | −5.64% | −13.31% | −14.99% |
| Today | +0.43% | −0.95% | −2.43% | −0.10% | −0.39% | −0.99% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All 000105.KS news ›Peptron ends Yuhan diabetes tech deal, keeps PT302 rights in South Korea
Peptron(087010) and Yuhan(000100) terminated a technology transfer contract for a diabetes treatment worth up to 4 billion won that they signed about 15 years ago. Unlike the original contract value, Peptron actually received only the 1…
Kyrgyz wrestler Yuhan Dogdurbek uulu won a silver medal at the World Championship
open.kg
Drugmaker Yuhan's historic headquarters wins Korea's top architectural honor
The Willow House / Courtesy of Yuhan Willow House, the historical former headquarters of Korean pharmaceutical pioneer Yuhan Corp., has won the Presidential Award — the grand prize at this year’s Korea Space Culture Awards, the Ministry of…
Yuhan's Lazcluze combination therapy tops $320 million in quarterly sales for first time
1:04 p.m. Oct 14, 2026 The quarterly revenue from the combined therapy of Yuhans' new non-small cell lung cancer drug Lazcluze, marketed as Leclaza in Korea, surpassed $300 million (400 billion won) for the first time. With the increasing…
Yuhan's Lazertinib Combo Therapy Tops $300 Million in Quarterly Sales for First Time
South Korea's Yuhan Corporation's lung cancer drug Lazertinib in combination with Johnson & Johnson's Rybrevant posted global sales of $320 million in the third quarter, surpassing the $300 million mark on a quarterly basis for the first…
Yuhan-Kimberly Brings Fan-Requested Kleenex Edition to Emart24
Product developed after viewers asked for it Name blends the Korean word for scrubbing clean with a leopard cat character Yuhan-Kimberly said on the 13th that its Kleenex Facial Tissue Sseukssak Edition has gone on sale exclusively at…
Yuhan accelerates global Leclaza growth as indications widen and reimbursement lags
Rising global uptake hinges on faster reimbursement as costly Leclaza–Rybrevant combo broadens use from surgery prep to post-resistance care Johnson & Johnson (J&J), which is responsible for global development and commercialization, has…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
biz.chosun.com4
-
en.sedaily.com2
-
finance.biggo.com2
-
mt.co.kr1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.